An immunological method to combine the measurement of active and total myeloperoxidase on the same biological fluid, and its application in finding inhibitors which interact directly with the enzyme.
ELISA; SIEFED; immunocapture; myeloperoxidase; specific activity
Abstract :
[en] Myeloperoxidase (MPO) is a pro-oxidant enzyme involved in inflammation, and the measurement of its activity in biological samples has emerged essential for laboratory and clinical investigations. We will describe a new method which combines the SIEFED (specific immunological extraction followed by enzymatic detection) and ELISA (ELISAcb) techniques to measure the active and total amounts of MPO on the same human sample and with the same calibration curve, as well as to define an accurate ratio between both the active and total forms of the enzyme. The SIEFED/ELISAcb method consists of the MPO extraction from aqueous or biological samples by immobilized anti-MPO antibodies coated onto microplate wells. After a washing step to eliminate unbound material, the activity of MPO is measured in situ by adding a reaction solution (SIEFED). Following aspiration of the reaction solution, a secondary anti-MPO antibody is added into the wells and the ELISAcb test is carried out in order to measure the total MPO content. To validate the combined method, a comparison was made with SIEFED and ELISA experiments performed separately on plasma samples isolated from human whole blood, after a neutrophil stimulation. The SIEFED/ELISAcb provides a suitable tool for the measurement of specific MPO activity in biological fluids and for the estimation of the inhibitory potential of a fluid. The method can also be used as a pharmacological tool to make the distinction between a catalytic inhibitor, which binds to MPO and inhibits its activity, and a steric inhibitor, which hinders the enzyme and prevents its immunodetection.
Research center :
CORD - Centre de l'Oxygène, Recherche et Développement - ULiège
Franck, Thierry ; Université de Liège > Centre de l'oxygène : Recherche et développement (C.O.R.D.)
MINGUET, Grégory ; Centre Hospitalier Universitaire de Liège - CHU > Department of Anaesthesia and Intensive Care Medicine
Delporte, C.
Derochette, Sandrine ; Université de Liège > Centre de l'oxygène : Recherche et développement (C.O.R.D.)
Zouaoui Boudjeltia, K.
Van Antwerpen, P.
GACH, Olivier ; Centre Hospitalier Universitaire de Liège - CHU > Department of Cardiology
Deby-Dupont, G.
Mouithys-Mickalad, Ange ; Université de Liège > Centre de l'oxygène : Recherche et développement (C.O.R.D.)
Serteyn, Didier ; Université de Liège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Anesthésiologie gén. et pathologie chirurg. des grds animaux
Language :
English
Title :
An immunological method to combine the measurement of active and total myeloperoxidase on the same biological fluid, and its application in finding inhibitors which interact directly with the enzyme.
Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997;89:3503-3521.
Zhu A, Ge D, Zhang J, Teng Y, Yuan C, Huang M, et al. Sputum myeloperoxidase in chronic obstructive pulmonary disease. Eur J Med Res 2014;19:12.
van der Veen BS, de Winther MP, Heeringa P. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 2009;11:2899-2937.
Malle E, Furtmuller PG, Sattler W, Obinger C. Myeloperoxidase: a target for new drug development? B J Pharmacol 2007;152:838-854.
Faith M, Sukumaran A, Pulimood AB, Jacob M. How reliable an indicator of inflammation is myeloperoxidase activity? Clinica Chimica Acta 2008;396:23-25.
Brennan ML, Hazen SL. Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment . Curr Opin Lipidol 2003;14:353-359.
Pulli B, Ali M, Forghani R, Schob S, Hsieh KL, Wojtkiewicz G, et al . Measuring myeloperoxidase activity in biological samples. PLoS One 2013;8:e67976.
Zhang N, Francis KP, Prakash A, Ansaldi D. Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of near-infrared nanoparticles . Nat Med 2013;19:500-505.
Gorudko IV, Cherkalina OS, Sokolov AV, Pulina MO, Zakharova ET, Vasil'ev VB, et al. [New approaches to the measurement of the concentration and peroxidase activity of myeloperoxidase in human blood plasma] . Bioorg Khim 2009;35:629-639.
Andrews PC, Krinsky NI. Quantitative determination of myeloperoxidase using tetramethylbenzidine as substrate . Anal Biochem 1982;127:346-350.
Shepherd J, Hilderbrand SA, Waterman P, Heinecke JW, Weissleder R, Libby P. A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages. Chem Biol 2007;14:1221-1231.
Grigorieva DV, Gorudko IV, Sokolov AV, Kosmachevskaya OV, Topunov AF, Buko IV, et al. Measurement of plasma hemoglobin peroxidase activity. Bull Exp Biol Med 2013;155:118-121.
Segelmark M, Persson B, Hellmark T, Wieslander J. Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin? Clin Exp Immunol 1997;108:167-174.
Carr AC, Myzak MC, Stocker R, McCall MR, Frei B. Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis. FEBS Lett 2000;487:176-180.
Graff G, Gamache DA, Brady MT, Spellman JM, Yanni JM. Improved myeloperoxidase assay for quantitation of neutrophil influx in a rat model of endotoxin-induced uveitis . J Pharmacol Toxicol Methods 1998;39:169-178.
Franck T, Kohnen S, Deby-Dupont G, Grulke S, Deby C, Serteyn D. A specific method for measurement of equine active myeloperoxidase in biological samples and in in vitro tests. J Vet Diagn Invest 2006;18:326-334.
Franck T, Kohnen S, Boudjeltia KZ, Van Antwerpen P, Bosseloir A, Niesten A, et al. A new easy method for specific measurement of active myeloperoxidase in human biological fluids and tissue extracts. Talanta 2009;80:723-729.
Pincemail J, Deby-Dupont G, Deby C, Thirion A, Torpier G, Faymonville ME, et al. Fast double antibody radioimmunoassay of human granulocyte myeloperoxidase and its application to plasma. J Immunol Methods 1991;137:181-191.
Deby-Dupont G, Pincemail J, Thirion A, Deby C, Lamy M, Franchimont P. Self-labeling of human polymorphonuclear leucocyte myeloperoxidase with125iodine. Experientia 1991;47:952-957.
Derochette S, Franck T, Mouithys-Mickalad A, Deby-Dupont G, Neven P, Serteyn D. Intra- and extracellular antioxidant capacities of the new water-soluble form of curcumin (NDS27) on stimulated neutrophils and HL-60 cells . Chem Biol Interact 2013;201:49-57.
Koelsch M, Mallak R, Graham GG, Kajer T, Milligan MK, Nguyen LQ, et al. Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations . Biochem Pharmacol 2010;79:1156-1164.
Chapman AL, Mocatta TJ, Shiva S, Seidel A, Chen B, Khalilova I, et al. Ceruloplasmin is an endogenous inhibitor of myeloperoxidase. J Biol Chem 2013;288:6465-6477.
Minguet G, de la Rebiere G, Franck T, Joris J, Serteyn D, Sandersen C. Sevoflurane inhibits equine myeloperoxidase release and activity in vitro. Vet Anaesth Analg 2013;40:166-175.
Gach O, Magne J, Franck T, Derochette S, Deby G, Serteyn D, et al. Clinical significance of active myeloperoxidase in carotid atherosclerotic plaques. Int J Cardiol 2011;152:149-151.
Stamp LK, Khalilova I, Tarr JM, Senthilmohan R, Turner R, Haigh RC, et al. Myeloperoxidase and oxidative stress in rheumatoid arthritis. Rheumatology (Oxford) 2012;51:1796-1803.
Nzeusseu Toukap A, Delporte C, Noyon C, Franck T, Rousseau A, Serteyn D, et al. Myeloperoxidase and its products in synovial fluid of patients with treated or untreated rheumatoid arthritis. Free Radic Res 2014;48:461-465.
Delporte C, Franck T, Noyon C, Dufour D, Rousseau A, Madhoun P, et al. Simultaneous measurement of protein-bound 3-chlorotyrosine and homocitrulline by LC-MS/MS after hydrolysis assisted by microwave: application to the study of myeloperoxidase activity during hemodialysis. Talanta 2012;99:603-609.
Zouaoui Boudjeltia K, Delporte C, Van Antwerpen P, Franck T, Serteyn D, Moguilevsky N, et al. Myeloperoxidase-Dependent LDL Modifications in Bloodstream Are Mainly Predicted by Angiotensin II, Adiponectin, and Myeloperoxidase Activity: A Cross-Sectional Study in Men . Mediators Inflamm 2013;2013:1-4.
Franck T, Grulke S, Deby-Dupont G, Deby C, Duvivier H, Peters E, Serteyn D. Development of an enzyme-linked immunosorbent assay for specific equine neutrophil myeloperoxidase measurement in blood. J Vet Diagn Invest 2005;17:412-419.
Olsen RL, Little C. Studies on the subunits of human myeloperoxidase. Biochem J 1984;222:701-709.
Ceusters JD, Serteyn DA, Minguet G, de la Rebiere de Pouyade G, Romainville J, Deby-Dupont GP, et al. An in vitro whole blood model to test the effects of different stimuli conditions on the release of myeloperoxidase and elastase by equine neutrophils. Vet Immunol Immunop 2012;150:221-227.
King CC, Jefferson MM, Thomas EL. Secretion and inactivation of myeloperoxidase by isolated neutrophils . J Leukoc Biol 1997;61:293-302.
Bakhautdin B, Goksoy Bakhautdin E, Fox PL. Ceruloplasmin has two nearly identical sites that bind myeloperoxidase . Biochem Biophys Res Commun 2014;453:722-727.
Sokolov AV, Ageeva KV, Cherkalina OS, Pulina MO, Zakharova ET, Prozorovskii VN, et al. Identification and properties of complexes formed by myeloperoxidase with lipoproteins and ceruloplasmin. Chem Phys Lipids 2010;163:347-355.
Delporte C, Boudjeltia KZ, Noyon C, Furtmuller PG, Nuyens V, Slomianny MC, et al. Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent post-translational oxidative modifications of apoB-100 . J Lipid Res 2014;55:747-757.
Franck T, Mouithys-Mickalad A, Robert T, Ghitti G, Deby-Dupont G, Neven P, Serteyn D. Differentiation between stoichiometric and anticatalytic antioxidant properties of benzoic acid analogues: a structure/redox potential relationship study. Chem Biol Interact 2013;206:194-203.
Soubhye J, Aldib I, Elfving B, Gelbcke M, Furtmüller PG, Podrecca M, et al. Design, Synthesis, and Structure-Activity Relationship Studies of Novel 3-Alkylindole Derivatives as Selective and Highly Potent Myeloperoxidase Inhibitors . J Med Chem 2013;56:3943-3958.
Franck T, Kohnen S, Grulke S, Neven P, Goutman Y, Peters F, et al. Inhibitory effect of curcuminoids and tetrahydrocurcuminoids on equine activated neutrophils and myeloperoxidase activity. Physiol Res 2008;57:577-587.
Marquez LA, Dunford HB. Interaction of acetaminophen with myeloperoxidase intermediates: optimum stimulation of enzyme activity. Arch Biochem Biophys 1993;305:414-420.
Chou TM, Greenspan P. Effect of acetaminophen on the myeloperoxidase-hydrogen peroxide-nitrite mediated oxidation of LDL. Biochim Biophys Acta 2002;1581:57-63.
Samygina VR, Sokolov AV, Bourenkov G, Petoukhov MV, Pulina MO, Zakharova ET, et al. Ceruloplasmin: macromolecular assemblies with iron-containing acute phase proteins . PLoS One 2013;8:e67145.
Gr iffin SV, Chapman PT, Lianos EA, Lockwood CM. The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies . Kidney Int 1999;55:917-925.
Chen J, Chen M, Liu Z, Zhao M. Inhibition of oxidative activity of myeloperoxidase by anti-myeloperoxidase antibodies from patients with microscopic polyangiitis . Beijing Da Xue Xue Bao 2008;40:155-159.
Boufadi Y, Soubhye J, Riazi A, Rousseau A, Vanhaeverbeek M, Nève J, et al. Characterization and Antioxidant Properties of Six Algerian Propolis Extracts: Ethyl Acetate Extracts Inhibit Myeloperoxidase Activity. Int J Mol Sci 2014;15:2327-2345.
Tsumbu CN, Deby-Dupont G, Tits M, Angenot L, Frederich M, Kohnen S, et al. Polyphenol content and modulatory activities of some tropical dietary plant extracts on the oxidant activities of neutrophils and myeloperoxidase . Int J Mol Sci 2012;13:628-650.